Melting of Northern Greenland during the last interglaciation

Using simulated climate data from the comprehensive coupled climate model IPSL CM4, we simulate the Greenland ice sheet (GrIS) during the Eemian interglaciation with the three-dimensional ice sheet model SICOPOLIS. The Eemian is a period 126 000 yr before present (126 ka) with Arctic temperatures comparable to projections for the end of this century. In our simulation, the northeastern part of the GrIS is unstable and retreats significantly, despite moderate melt rates. This result is found to be robust to perturbations within a wide parameter space of key parameters of the ice sheet model, the choice of initial ice temperature, and has been reproduced with climate forcing from a second coupled climate model, the CCSM3. It is shown that the northeast GrIS is the most vulnerable. Even a small increase in melt removes many years of ice accumulation, giving a large mass imbalance and triggering the strong ice-elevation feedback. Unlike the south and west, melting in the northeast is not compensated by high accumulation. The analogy with modern warming suggests that in coming decades, positive feedbacks could increase the rate of mass loss of the northeastern GrIS, exceeding the recent observed thinning rates in the south.

Keratin 8 sequence variants in patients with pancreatitis and pancreatic cancer

Keratin 8 (KRT8) is one of the major intermediate filament proteins expressed in single-layered epithelia of the gastrointestinal tract. Transgenic mice over-expressing human KRT8 display pancreatic mononuclear infiltration, interstitial fibrosis and dysplasia of acinar cells resulting in exocrine pancreatic insufficiency. These experimental data are in accordance with a recent report describing an association between KRT8 variations and chronic pancreatitis. This prompted us to investigate KRT8 polymorphisms in patients with pancreatic disorders. The KRT8 Y54H and G62C polymorphisms were assessed in a cohort of patients with acute and chronic pancreatitis of various aetiologies or pancreatic cancer originating from Austria (n=16), the Czech Republic (n=90), Germany (n=1698), Great Britain (n=36), India (n=60), Italy (n=143), the Netherlands (n=128), Romania (n=3), Spain (n=133), and Switzerland (n=129). We also studied 4,234 control subjects from these countries and 1,492 control subjects originating from Benin, Cameroon, Ethiopia, Ecuador, and Turkey. Polymorphisms were analysed by melting curve analysis with fluorescence resonance energy transfer probes. The frequency of G62C did not differ between patients with acute or chronic pancreatitis, pancreatic adenocarcinoma and control individuals. The frequency of G62C varied in European populations from 0.4 to 3.8%, showing a northwest to southeast decline. The Y54H alteration was not detected in any of the 2,436 patients. Only 3/4,580 (0.07%) European, Turkish and Indian control subjects were heterozygous for Y54H in contrast to 34/951 (3.6%) control subjects of African descent. Our data suggest that the KRT8 alterations, Y54H and G62C, do not predispose patients to the development of pancreatitis or pancreatic cancer.